Description
Administered subcutaneously.

Guidelines/Instructions
  • This modifier is informational only and may be submitted with all injection codes
  • All providers that submit claims for injections of erythropoiesis stimulating agents (ESA) for ESRD beneficiaries are encouraged to include HCPCS modifier JA on the claim to indicate an intravenous administration or HCPCS modifier JB to indicate a subcutaneous administration
  • At this time, reporting these modifiers is voluntary

References

Contact Palmetto GBA JJ Part B Medicare

Provider Contact Center: 877-567-7271

Email JJ Part B

Contact a specific JJ Part B department


Click to Chat Now